| SAKAR HEALTHCARE  | 
The Current P/E Ratio of SAKAR HEALTHCARE  is 40.31.
                
| Share Price | ₹358.9 | Oct 27,2025 | 
| Market Cap | ₹796.6 Cr | |
| Earnings-TTM | ₹19.8 Cr | TTM-Consolidated Results | 
| Price/Earnings | 40.31x | Calculated as Market Cap/Earnings | 
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SAKAR HEALTHCARE
                    P/E = 
                    Market Capitalization 
                    / Net Income 
                    
                    or, using per-share numbers:
                    
                    P/E = Stock Price / 
                    Earnings Per Share (EPS)
                
               
                                     Current Market Cap [ ₹796.6 Cr] as on Oct 27,2025                     
                    (/) Earnings [ ₹19.8 Cr] based on TTM-Consolidated Results
                                    
                
                (=) P/E Ratio [ 40.31x ]
            
Thus, for SAKAR HEALTHCARE , the investors are currently willing to pay 40.31 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SAKAR HEALTHCARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SAKAR HEALTHCARE over the last five years.
Historical PE (Price/Earnings) ratio chart of SAKAR HEALTHCARE
PE Ratio Performance Analysis for SAKAR HEALTHCARE
- SAKAR HEALTHCARE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 27.63x.
- SAKAR HEALTHCARE 's operated at median p/e ratio of 16.54x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SAKAR HEALTHCARE 's p/e ratio peaked in Mar2024 at 68.64x.
- SAKAR HEALTHCARE 's p/e ratio hit its five-year low in Mar2020 of 7.77x.
How does SAKAR HEALTHCARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap | 
|---|---|---|---|
| SAKAR HEALTHCARE | 19.76 | 40.31 | 796.6 | 
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 39.04 | 406,471.0 | 
| DIVIS LABORATORIES LTD | 2,306.00 | 74.72 | 172,294.0 | 
| CIPLA LTD | 5,406.81 | 23.66 | 127,946.0 | 
| TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.78 | 121,691.0 | 
| DR REDDYS LABORATORIES LTD | 5,721.40 | 18.74 | 107,214.0 | 
| MANKIND PHARMA LTD | 1,905.51 | 52.31 | 99,677.0 | 
| ZYDUS LIFESCIENCES LTD | 4,637.80 | 22.00 | 102,017.0 | 
| LUPIN LTD | 3,722.18 | 23.59 | 87,812.2 | 
| AUROBINDO PHARMA LTD | 3,417.93 | 18.60 | 63,589.1 | 
| ABBOTT INDIA LTD | 1,452.29 | 43.57 | 63,282.4 | 
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SAKAR HEALTHCARE 's P/E Ratio
| Top 10 Industry Peers | PE Ratio | 
|---|---|
| Min industry PE | 18.60x | 
| Max industry PE | 74.72x | 
| Median industry PE | 39.04x | 
| Average industry PE | 37.94x | 
You may also like the below Video Courses
 
                                     
                                     
                                    